FDA approves HIV Genotyping Assay test for better control of resistant drugs to control AIDS

FDA has authorized the marketing of a test to detect human immunodeficiency virus (HIV) Type-1 drug resistance mutations using next-generation sequencing technology. The Sentosa SQ HIV Genotyping Assay is the first HIV drug resistance assay that uses NGS technology that the FDA has authorized for marketing in the U. This ability to rationally select treatments for patients about to start or already taking antiviral therapy provides another tool in our ongoing fight against HIV,” said director of the FDA’s Center for Biologics Evaluation and Research.

“Today’s authorization offers health care providers a new tool in helping to select treatment options for their patients. The right combination of antivirals can lower viral loads, or the amount of virus in the bloodstream, and help keep patients with HIV healthy for many years. However, according to a recent report from the Centers for…